Oric Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Oric Pharmaceuticals Stock Summary

Oric Pharmaceuticals competes with Seer, Anebulo Pharmaceuticals, Cullinan Oncology, C4 Therapeutics, and Molecular Partners. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Oric Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.

Oric Pharmaceuticals Key Financial Ratios

Oric Pharmaceuticals Key Balance Sheet Accounts

Oric Pharmaceuticals Key Income Statement Accounts

Oric Pharmaceuticals Key Cash Accounts

Oric Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oric Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oric Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oric Pharmaceuticals competition to find correlations between indicators driving Oric Pharmaceuticals's intrinsic value. More Info.Oric Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Oric Pharmaceuticals' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oric Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Oric Pharmaceuticals Systematic Risk

Today, most investors in Oric Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Oric Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Oric Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Oric Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oric Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oric Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oric Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oric Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.